Identification of compounds exhibiting inhibitory activity toward the Pseudomonas tolaasii toxin tolaasin I using in silico docking calculations, NMR binding assays, and in vitro hemolytic activity assays

Younggiu Lee, Yoonkyung Woo, Soohyun Lee, Kyungrai Kang, Yeonjoong Yong, Jae Kyung Kim, Kwang Pyo Kim, Min Hee Kim, Young Kee Kim, Yoongho Lim

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)

Abstract

Using in silico docking calculations, NMR analysis of target-ligand binding, and hemolytic activity assays, we searched a 30,000-compound library for an effective inhibitor of tolaasin I, a Pseudomonas tolaasii toxin that causes virulent infection in mushrooms. Of more than 30,000 compounds screened in silico, two compounds were selected. One of these compounds, sorbitololeic acid, bound to tolaasin I and inhibited its hemolytic activity in vitro. Therefore, sorbitololeic acid can be a potential inhibitor of tolaasin I.

Original languageEnglish
Pages (from-to)4321-4324
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume19
Issue number15
DOIs
Publication statusPublished - 1 Aug 2009

Bibliographical note

Funding Information:
This work was supported by grants from the Technology Development Program for Agriculture and Forestry (Agricultural R&D Promotion Center), KRF-2006-005-J03402 (KRF), M10751050003-07N5105-00310 (KOSEF), Biogreen 21 (RDA), and Agenda 11-30-68 (NIAS). Younggiu Lee and Yoonkyung Woo contributed equally to this work.

Keywords

  • Hemolytic activity
  • In silico docking
  • NMR
  • Pseudomonas tolaasii
  • Tolaasin

Fingerprint

Dive into the research topics of 'Identification of compounds exhibiting inhibitory activity toward the Pseudomonas tolaasii toxin tolaasin I using in silico docking calculations, NMR binding assays, and in vitro hemolytic activity assays'. Together they form a unique fingerprint.

Cite this